Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Grant | Utility: 2,4-dihydroxy-nicotinamides as APJ agonists Filling date: 6 Sep 2025 Issue date: 27 Aug 2019 |
Application | Utility: OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: PYRROLE AMIDES AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Grant | Utility: Phthalazinones and isoquinolinones as rock inhibitors Filling date: 6 Sep 2025 Issue date: 20 Aug 2019 |
Application | Utility: ANTIBODIES TO CD40 Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: BSL2v2c2-Ig POLYPEPTIDES Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ANTIBODIES AGAINST TIM3 AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: MONOCYCLIC HETEROARYL SUBSTITUTED COMPOUNDS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Grant | Utility: Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Filling date: 6 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof Filling date: 6 Sep 2025 Issue date: 13 Aug 2019 |
Application | Utility: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS Filling date: 6 Sep 2025 Issue date: 8 Aug 2019 |
Grant | Utility: Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Filling date: 6 Sep 2025 Issue date: 6 Aug 2019 |
Grant | Utility: Methods of treatment using CTLA4 mutant molecules Filling date: 6 Sep 2025 Issue date: 6 Aug 2019 |
Application | Utility: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS Filling date: 6 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME Filling date: 6 Sep 2025 Issue date: 1 Aug 2019 |
Showing 750 to 772 of 772 patents.